Goldman Sachs Group Inc Enveric Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$12.5 - $52.0 $736,437 - $3.06 Million	-58,915 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$46.5 - $104.0 $2.74 Million - $6.13 Million	58,915 New	58,915 $55,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.